Form 4 for STTK Shattuck Labs, Inc.
Accepted 2025-01-28 00:00:00 ET · period of report 2025-01-25 · accession 0000950170-25-010004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-28 | 2025-01-25 | STTK | Pandite Arundathy N. | Chief Medical Off | F - Tax | $1.16 | -3,211 | 206.3K | -2% | -$3,725 |
| D | 2025-01-28 | 2025-01-28 | STTK | Pandite Arundathy N. | Chief Medical Off | A - Grant | $0.00 | +206.2K | 206.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-25 | F | D | 3,211 | $1.16 | 206,265 | D | — | — | |
| 2 | Derivative | Common Stock | 2025-01-28 | A | A | 206,200 | $0.00 | 206,200 | D | $1.18 · — to 2035-01-28 | 206,200 Common Stock | (F1) This option represents a right to purchase a total of 206,200 shares of the Issuer's common stock, one quarter of which will vest on January 28, 2026, with the remaining three quarters vesting in equal monthly installments through January 28, 2029, subject to the Reporting Person's continued service to the Issuer. |